MGC BioPQQ, a subsidiary of the MGC Group, is a leading player in the biotechnology industry, headquartered in Japan. Established in 2015, the company has rapidly gained recognition for its innovative approach to health and wellness, particularly in the development of bioactive compounds. Specialising in the production of Pyrroloquinoline Quinone (PQQ), MGC BioPQQ offers unique products that support cellular energy and overall vitality. Their commitment to quality and scientific research has positioned them as a trusted name in the market, catering to both domestic and international clients. With a focus on sustainability and cutting-edge technology, MGC BioPQQ continues to make significant strides in the health supplement sector, contributing to advancements in nutritional science and enhancing consumer well-being.
How does MGC BioPQQ's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
MGC BioPQQ's score of 34 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, MGC BioPQQ reported total carbon emissions of approximately 10.7 billion kg CO2e. This figure includes Scope 1 emissions of about 715 million kg CO2e, Scope 2 emissions of approximately 682 million kg CO2e, and Scope 3 emissions amounting to about 9.3 billion kg CO2e. The Scope 3 emissions are particularly significant, with major contributions from purchased goods and services (about 5.3 billion kg CO2e) and end-of-life treatment of sold products (approximately 2.6 billion kg CO2e). MGC BioPQQ has set ambitious climate commitments, aiming for a transition towards a zero-carbon society by 2050. This long-term target encompasses both Scope 1 and Scope 2 emissions, reflecting the company's dedication to reducing its carbon footprint. The initiatives are part of a broader strategy to promote energy transition and sustainability. The emissions data is sourced from Mitsubishi Gas Chemical Company, Inc., indicating a corporate family relationship that informs MGC BioPQQ's environmental impact assessments. The company is actively working towards its climate goals, although specific reduction percentages have not been disclosed.
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 749,010,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 222,812,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 7,134,439,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 |
MGC BioPQQ's Scope 3 emissions, which decreased by 1% last year and increased by approximately 30% since 2016, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 57% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MGC BioPQQ has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

